Goldman Sachs’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-114,476
| Closed | -$11.2M | – | 4872 |
|
|
2015
Q1 | $11.2M | Buy |
114,476
+1,197
| +1% | +$117K | ﹤0.01% | 1613 |
|
|
2014
Q4 | $10.5M | Sell |
113,279
-9,839
| -8% | -$913K | ﹤0.01% | 1588 |
|
|
2014
Q3 | $8.47M | Sell |
123,118
-982
| -0.8% | -$67.5K | ﹤0.01% | 1688 |
|
|
2014
Q2 | $13M | Sell |
124,100
-10,594
| -8% | -$1.11M | ﹤0.01% | 1482 |
|
|
2014
Q1 | $11.2M | Sell |
134,694
-16,713
| -11% | -$1.39M | ﹤0.01% | 1545 |
|
|
2013
Q4 | $9.8M | Buy |
151,407
+11,445
| +8% | +$741K | ﹤0.01% | 1592 |
|
|
2013
Q3 | $8.87M | Buy |
139,962
+16,097
| +13% | +$1.02M | ﹤0.01% | 1556 |
|
|
2013
Q2 | $5.2M | Buy |
+123,865
| New | +$5.2M | ﹤0.01% | 1739 |
|